Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy (Q33368725)

26 July 2017

1 reference

title

Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy (English)

1 reference

26 July 2017

Patrick Chames

2

0 references

Reno Debets

series ordinal

5

object named as

Reno Debets

1 reference

26 July 2017

Ralph Willemsen

1

1 reference

26 July 2017

Erik Schooten

series ordinal

3

1 reference

26 July 2017

Jan Willem Gratama

series ordinal

4

1 reference

26 July 2017

publication date

1 November 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

73

1 reference

26 July 2017

issue

11

1 reference

26 July 2017

page(s)

1093-1099

1 reference

Microarrays to identify new therapeutic strategies for cancer

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Recognition of insulin on MHC-class-II-expressing L929 cells by antibody and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Natural and designer binding sites made by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

The new face of bispecific antibodies: targeting cancer and much more

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Genetic engineering of T cell specificity for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Monoclonal T-cell receptors: new reagents for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

Optimizing the exogenous antigen loading of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

The promise of cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

Immunotherapy through TCR gene transfer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20644

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20644

1 reference

26 July 2017

1 reference